论文部分内容阅读
子宫肉瘤是一组少见的女性生殖系统恶性肿瘤,有广泛的组织学类型,3种主要亚型分别是子宫平滑肌肉瘤、子宫内膜间质肉瘤和恶性苗勒管混合瘤。治疗方法近年主张参照1988年国际妇产科联盟(FIGO)的子宫内膜癌手术病理分期标准和美国国立综合癌症网(The National Comprehensive Cancer Net-work,NCCN)规范进行,包括手术治疗、放疗、化疗和激素治疗等,预后欠佳。近年国际上致力于研究新的综合治疗方案改善患者预后,热点集中在生物治疗。对生物治疗的研究进展综述。
Uterine sarcoma is a rare group of female reproductive system malignancies with a wide range of histological types. The three major subtypes are uterine leiomyosarcoma, endometrial stromal sarcoma and malignant Mullerian mixed tumor. In recent years, treatment has been advocated in the 1988 International Union of Gynecology and Obstetrics (FIGO) endometrial cancer surgical staging criteria and the National Comprehensive Cancer Network (The National Comprehensive Cancer Net-work, NCCN) specification, including surgery, radiotherapy, Chemotherapy and hormone therapy, poor prognosis. In recent years, the international community is committed to studying new integrated treatment programs to improve patient outcomes, focusing on biological treatment. Review of research advances in biotherapy.